Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia After Laparoscopic Colonic Resection
Colonic Cancer, Rectal Cancer, Colonic Diverticulum
About this trial
This is an interventional treatment trial for Colonic Cancer focused on measuring TAP block, Laparoscopic hemicolectomy, Laparoscopic anterior resection, laparoscopic colonic resection
Eligibility Criteria
Inclusion Criteria:
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 18 years or above.
- Undergoing elective laparoscopic high anterior resection without stoma or laparoscopic right hemicolectomy.
- American Society of Anaesthetists physical status (ASA) 1-3
Exclusion Criteria:
- Opioid tolerance
- Chronic abdominal pain
- Allergy/Intolerance: Morphine, local anaesthetics
- BMI>35 Kg/M2
- Previous major abdominal surgery
- High likelihood of conversion to open procedure
- Patients unable to communicate in written and spoken English
- Weight less than 50 kg
Sites / Locations
- The Churchill Hospital, Oxford Radcliffe Hospitals NHS trust
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
TAP block
Local anaesthetic infiltration
Patients in this arm will receive ultrasound guided TAP bock with Bupivacaine 0.25% 20ml per side or to a maximum 1mg/kg per side and the skin puncture will be covered with a small plaster
Laparoscopic port sites and specimen extraction site will be infiltrated with a total of 40 mls 0.25% bupivacaine subcutaneously at the end of the procedure in the control group and plasters will be stuck on either side approximately where a skin puncture for tap block would be made.